Michael C. Heinrich | Akateeminen Kirjakauppa

Innovative Leukemia and Lymphoma Therapy provides a complete and up-to-date overview of the exciting new treatment modalities in leukemia and lymphoma that are being introduced in the clinic today. Written by international experts in the field, this volume examines clinical studies on topics such as:



tyrosine kinase inhibitors, histon deacetylase inhibitors, and farnesyl transferase inhibitors
radioimmunotherapy, gene-directed therapy, and immunotherapy by vaccination
monoclonal antibodies
anti-angiogenesis approaches

Within each chapter, this well-illustrated, comprehensive source provides a summary of the rationale for treatment, the pathways that are involved, and the translational research to students, scientists, and clinicians. In addition, this book focuses on the concerns of conventional but novel anticancer agents, modulation of classical multidrug resistance, and modulators of single agent drug resistance.